Ng Hans K H, Harikumar Kaleeckal G, Miller Laurence J, Chow Billy K C
School of Biological Sciences, The University of Hong Kong, Hong Kong, China.
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, Arizona, 85259, United States of America.
PLoS One. 2016 Sep 20;11(9):e0163086. doi: 10.1371/journal.pone.0163086. eCollection 2016.
The involvement of secretin (SCT) and secretin receptor (SCTR) in regulating body water homeostasis is well established. Identified as one of the vasopressin (Vp)-independent mechanisms in fluid balance, SCT regulates aquaporin 2 (AQP2) in the kidney distal collecting duct cells through activating intracellular cAMP production. This ability to bypass Vp-mediated water reabsorption in kidney implicates SCT's potential to treat nephrogenic diabetes insipidus (NDI). Research on NDI in the past has largely been focused on the searching for mutations in vasopressin receptor 2 (AVPR2), while the functional relationship between SCTR, AVPR2 and NDI remains unclear. Here, we demonstrate the interaction between SCTR and AVPR2 to modulate cellular signaling in vitro. Interestingly, we show in this report that upon heteromer formation with SCTR, R137H, a NDI-causing AVPR2 mutant that is defective in trafficking to cell surface, can functionally be rescued. Our data may provide an explanation for this clinically mild case of NDI, and insights into the pathological development of NDI in the future.
促胰液素(SCT)和促胰液素受体(SCTR)参与调节机体水稳态已得到充分证实。作为体液平衡中一种不依赖抗利尿激素(Vp)的机制,SCT通过激活细胞内cAMP生成来调节肾远曲小管细胞中的水通道蛋白2(AQP2)。这种绕过Vp介导的肾脏水重吸收的能力表明SCT有治疗肾性尿崩症(NDI)的潜力。过去对NDI的研究主要集中在寻找抗利尿激素受体2(AVPR2)的突变,而SCTR、AVPR2与NDI之间的功能关系仍不清楚。在此,我们证明了SCTR与AVPR2之间的相互作用可在体外调节细胞信号传导。有趣的是,我们在本报告中表明,与SCTR形成异源二聚体后,R137H(一种导致NDI的AVPR2突变体,在转运至细胞表面方面存在缺陷)在功能上可得到挽救。我们的数据可能为这种临床上症状较轻的NDI病例提供一种解释,并为未来NDI的病理发展提供见解。